Pharmacogenomics Market Forecast, Revenue, Demand, Growth and Key Companies Valuation by 2028
The global Pharmacogenomics
Market is expected to reach USD 11.97 Billion by 2027, according to
a new report by Emergen Research. The global pharmacogenomics (PGx) market is
growing at a substantial pace owing to the growing demand for personalized
therapy, increasing prevalence of target chronic diseases, technological
advancements, favorable government initiatives, availability of financial
support for research and development.
The report provides Pharmacogenomics market forecast, supported by
detailed insights historical data and revenues, past and current market trends,
industry trends, consumer trends, market size, market share, market growth,
along with ranging impacts of each factor and driver. It also provides analysis
of various factors expected to restrain or limit potential growth in market
size over the forecast period, 2020–2028. The report includes profiles of major
players in the market, strategies being employed, mergers, acquisitions, recent
developments, agreements, contracts, new product development and launches,
segment revenue, investment details as well as financials.
Download FREE Sample Brochure (Customized Sample PDF File
delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/88
Global Pharmacogenomics market forecast has been provided
following thorough study, focus, comparison, and analysis of a varying range of
factors and past market forecast and present outcomes. Pharmacogenomics Market
forecast is made possible through, but has not been limited to, a study and
analysis of a variety of factors and trends, and these are verified through
interviews with industry experts and companies operating in the market.
Rising focus by major companies on product/service expansion into
new and untapped domestic markets, increasing investments in strategic
agreements, favourable government policies and regulations, and growing
competition in the market are some major trends observed in the
Pharmacogenomics market. Development of more advanced offerings is driving
rising demand and deployment in respective sectors/industries, and this is
expected to drive Pharmacogenomics market revenue growth to a significant
extent over the forecast period.
Top key vendors in Pharmacogenomics Market include are:
The global Pharmacogenomics
Market is expected to reach USD 11.97 Billion by 2027, according to
a new report by Emergen Research. The global pharmacogenomics (PGx) market is
growing at a substantial pace owing to the growing demand for personalized
therapy, increasing prevalence of target chronic diseases, technological
advancements, favorable government initiatives, availability of financial
support for research and development.
On the basis of the end users/applications, this report focuses on
the status and outlook for major applications/end users, consumption (sales),
market share and growth rate for each application, including
For the purpose of this report, Emergen Research has segmented
into the global Pharmacogenomics Market on the basis of products and services,
technology, application, end-use, and region:
- Product and
Services Outlook (Revenue, USD Billion; 2017-2027)
- Products
1.
Kits
2.
Assays and Reagents
3.
Instruments
4.
Software
- Services
1.
Genotyping
2.
SNP Identification
3.
Pharmacogenetic Testing
4.
Other Services
- Technology
Outlook (Revenue, USD Billion; 2017-2027)
- Polymerase
Chain Reaction (PCR)
1.
Real-Time PCR
2.
qPCR
3.
Digital PCR
- DNA
Sequencing/Next Generation Sequencing (NGS)
- Nucleic Acid
Amplification Tests (NAATs)
- Mass
Spectrometry
- Gel
Electrophoresis
- Hybridization
1.
Fluorescence In Situ Hybridization (FISH)
2.
Chromogenic In Situ Hybridization (CISH)
3.
Others
- Microarray
- Others
- Application
Outlook (Revenue, USD Billion; 2017-2027)
- Oncology
- Infectious
Diseases
- Neurology/Psychiatry
- Cardiovascular
- Others
- End-Use
Outlook (Revenue, USD Billion; 2017-2027)
- Research
Organization
- Pharmaceutical
Companies
- Diagnostic
Centers
- Others
Browse Full Report Description with TOC@ https://www.emergenresearch.com/industry-report/pharmacogenomics-market
Incorporated with Info-graphics, charts, 70 tables and 85 figures,
this 250-page research report “Pharmacogenomics Market Size, Type, Application,
End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2020
- 2027” is based on a complete research of the entire Global market and
covering all its sub-segments through comprehensively thorough classifications.
Insightful analysis and assessment are created from superior primary and
secondary information sources with data and information derived from industry
specialists across the value chain.
Region wise performance of the Pharmacogenomics industry
North America Pharmacogenomics market forecast is expected to
remain significantly positive in terms of revenue share between 2020 and 2028.
In addition, North America Pharmacogenomics market revenue share is expected to
remain comparatively larger than that of other regional markets from 2020 to
2028.
Asia Pacific registered fastest revenue CAGR in 2020, and the
Pharmacogenomics market forecast is that this trend is expected to continue
going ahead. Market forecast states that revenue share contribution from China,
India, and South Korea is expected to remain robust till 2028.
Europe Pharmacogenomics market forecast is positive currently,
with revenue growth expected to remain steady between 2020 and 2028. Robust
focus on research and development initiatives by major firms and changing
trends and demographics in countries in the region are some factors expected to
continue to support Pharmacogenomics market growth.
Geographically, this report studies the key regions, focuses on
product sales, value, market share and growth opportunity in these regions,
covering:
- United States
- Europe
- China
- Japan
- Southeast Asia
- India
We can also provide the customized separate regional or
country-level reports, for the following regions:
North America, United States, Canada, Mexico, Asia-Pacific, China,
India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of
Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of
Europe, Central & South America, Brazil, Argentina, Rest of South America,
Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East &
Africa
Request customized copy of Pharmacogenomics report@ https://www.emergenresearch.com/request-for-customization/88
The research provides answers to the following key questions:
- What will be the
growth rate and the market size of the Pharmacogenomics industry for the
forecast period 2020-2027?
- What are the
major driving forces expected to impact the development of the
Pharmacogenomics market across different regions?
- Who are the
major driving forces expected to decide the fate of the Pharmacogenomics
industry worldwide?
- Who are the
prominent market players making a mark in the Pharmacogenomics market with
their winning strategies?
- Which
Pharmacogenomics industry trends are likely to shape the future of the
industry during the forecast period 2020-2027?
- What are the key
barriers and threats believed to hinder the development of the industry?
- What are the
future opportunities in the Pharmacogenomics market?
Table of Content
Chapter 1. Methodology & Sources
1.1. Pharmacogenomics Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1.
Primary
1.4.2. Secondary
1.4.3. Paid
Sources
1.5. Pharmacogenomics Market Estimation
Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2021-2028
Chapter 3. Key Insights
Chapter 4. Pharmacogenomics Market Segmentation & Impact
Analysis
4.1. Pharmacogenomics Market Material
Segmentation Analysis
4.2. Industrial Outlook
4.2.1.
Pharmacogenomics Market indicators analysis
4.2.2.
Pharmacogenomics Market drivers analysis
4.2.2.1. Rapid urbanization and industrialization
4.2.2.2. Stringent government regulations regarding carbon emissions
4.2.2.3. Increasing prevalence of respiratory diseases
4.2.2.4. Rising need to enhance indoor air quality
4.2.3.
Pharmacogenomics Market restraints analysis
4.2.3.1. High cost associated with the maintenance of Pharmacogenomics products
4.2.3.2. Availability of renewable sources of energy
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 10. Competitive Landscape
10.1. Pharmacogenomics Market Revenue Share By
Manufacturers
10.2. Mergers & Acquisitions
10.3. Competitor’s Positioning
10.4. Strategy Benchmarking
10.5. Vendor Landscape
10.5.1. Raw
Material Suppliers
10.5.1.1. North America
10.5.1.2. Europe
10.5.1.3. Asia Pacific
10.5.1.4. Middle East & Africa
10.5.1.5. Latin America
10.5.2.
Distributors
10.5.2.1. North America
10.5.2.2. Europe
10.5.2.3. Asia Pacific
10.5.2.4. Middle East & Africa
10.5.2.5. Latin America
10.5.3.
Others
Continued….
Avail Discount on Pharmacogenomics Market Report@ https://www.emergenresearch.com/request-discount/88
Why Choose Emergen Research?
1.
Strong Industry Focus
2.
Extensive Product Offerings
3.
Customer Research Services
4.
Robust Research Methodology
5.
Comprehensive Reports
6.
Latest Technological Developments
7.
Value Chain Analysis
8.
Potential Market Opportunities
9.
Growth Dynamics
10.
Quality Assurance
11.
Post-sales Support
Read similar reports by Emergen Research:
Blockchain
Supply Chain Market
Carbon
Neutral Data Center Market
Non-Volatile
Memory Express Market
Green
Technology and Sustainability Market
Hemodynamic
Monitoring Devices Market
Healthcare
Distribution Market
Comments
Post a Comment